(2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide

C30H36N2O3S — CID 158106707

IUPAC(2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide
SMILESC=CC(=O)CC[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)CCC)Cc1nc2ccc(CC)cc2s1
InChIInChI=1S/C30H36N2O3S/c1-4-10-26(34)19-23(20-29-32-27-16-13-21(5-2)18-28(27)36-29)30(35)31-24(14-15-25(33)6-3)17-22-11-8-7-9-12-22/h6-9,11-13,16,18,23-24H,3-5,10,14-15,17,19-20H2,1-2H3,(H,31,35)/t23-,24+/m0/s1
InChIKeyVERVQCBQJIPSLQ-BJKOFHAPSA-N
MW504.70 g/mol
LogP6.04
Rot. Bonds15

About (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide

(2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide (PubChem CID 158106707) has the molecular formula C30H36N2O3S and a molecular weight of 504.70 g/mol. Its IUPAC name is (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide.

Molecular Properties

Compound Name(2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide
PubChem CID158106707
Molecular FormulaC30H36N2O3S
Molecular Weight504.70 g/mol
Exact Mass504.24
IUPAC Name(2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide
SMILESC=CC(=O)CC[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)CCC)Cc1nc2ccc(CC)cc2s1
InChIInChI=1S/C30H36N2O3S/c1-4-10-26(34)19-23(20-29-32-27-16-13-21(5-2)18-28(27)36-29)30(35)31-24(14-15-25(33)6-3)17-22-11-8-7-9-12-22/h6-9,11-13,16,18,23-24H,3-5,10,14-15,17,19-20H2,1-2H3,(H,31,35)/t23-,24+/m0/s1
InChIKeyVERVQCBQJIPSLQ-BJKOFHAPSA-N
XLogP6.04
TPSA76.13 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds15
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500504.70
LogP ≤ 56.04
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide?
The IUPAC name of (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide (CID 158106707) is (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide.
What is the SMILES notation for (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide?
The canonical SMILES for (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide is C=CC(=O)CC[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)CCC)Cc1nc2ccc(CC)cc2s1.
What is the InChIKey of (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide?
The InChIKey is VERVQCBQJIPSLQ-BJKOFHAPSA-N. The full InChI is InChI=1S/C30H36N2O3S/c1-4-10-26(34)19-23(20-29-32-27-16-13-21(5-2)18-28(27)36-29)30(35)31-24(14-15-25(33)6-3)17-22-11-8-7-9-12-22/h6-9,11-13,16,18,23-24H,3-5,10,14-15,17,19-20H2,1-2H3,(H,31,35)/t23-,24+/m0/s1.
What are the key properties of (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide?
(2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide has a molecular weight of 504.70 g/mol, XLogP of 6.04, 15 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[(6-ethyl-1,3-benzothiazol-2-yl)methyl]-4-oxo-N-[(2R)-5-oxo-1-phenylhept-6-en-2-yl]heptanamide is sourced from PubChem (CID 158106707), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).